Related references
Note: Only part of the references are listed.The temporal profile of the anti-PF4/heparin immune response
Andreas Greinacher et al.
BLOOD (2009)
Studies of the immune response in heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
BLOOD (2009)
Optimization of a murine immunization model for study of PF4/heparin antibodies
S. Suvarna et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Treatment and prevention of heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
CHEST (2008)
Prevention of venous thromboembolism
William H. Geerts et al.
CHEST (2008)
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings
A. Greinacher et al.
THROMBOSIS RESEARCH (2008)
Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
BLOOD (2006)
Heparin-induced thrombocytopenia
Gowthami M. Arepally et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The management of heparin-induced thrombocytopenia
D Keeling et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia
D Juhl et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings
GK Lo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Risk for heparin-induced thrombocytopenia. with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
N Martel et al.
BLOOD (2005)
Acquired haemophilia in a patient with gram-negative urosepsis and bladder cancer
M Kreuter et al.
HAEMOPHILIA (2005)
An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients
TE Warkentin et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcγRIIA
MP Reilly et al.
BLOOD (2001)
Share Paper
